Search the Newsreel

Bridgford Foods (BRID) Gains 1.66% to $6.42 as Traders Eye $6.74 Hurdle - Advance Decline Volume

Joanne Donovan Sells 2,919 Shares of Edgewise Therapeutics (NASDAQ:EWTX) Stock

StoneBridge Acquisition II (APAC): Clear Street LLC discloses 5.0% common stock stake

Edgewise Therapeutics (NASDAQ:EWTX) CEO Kevin Koch Sells 17,971 Shares of Stock

Badger Meter Raises Quarterly Dividend to $0.44 a Share From $0.40, Payable Sept. 11 to Holders of Record Aug. 28

Badger Meter has increased its quarterly dividend from $0.40 to $0.44 per share. The dividend is scheduled to be paid on September 11, 2026, to shareholders who are on record as of August 28, 2026. This announcement reflects a positive financial adjustment for the …

Edgewise Therapeutics (NASDAQ:EWTX) CMO Sells 6,522 Shares

Edgewise Therapeutics CMO Joanne Donovan recently sold 6,522 shares of EWTX stock for $285,989.70 to cover tax withholding obligations on vested equity awards, reducing her holdings by 36.1%. Despite this insider sale and a quarterly earnings miss, the company's shares rose 2.3%, and analysts …

Insider Selling: Edgewise Therapeutics (NASDAQ:EWTX) Insider Sells 5,901 Shares

Edgewise Therapeutics (NASDAQ:EWTX) insider Alan Russell sold 5,901 shares of the company's stock on August 12th, 2026, totaling approximately $258,051. This sale was conducted to cover tax withholding obligations related to vested equity awards. Despite this insider selling, analysts maintain a "Moderate Buy" consensus …

Edgewise Therapeutics (EWTX) CSO gets 97,500-share equity awards, sells shares for taxes

Edgewise Therapeutics' Chief Scientific Officer, Alan J. Russell, reported equity transactions on August 12, 2026, which included exercising Restricted Stock Units and selling 5,901 shares to cover tax withholding obligations. Additionally, Russell received new equity awards comprising 32,500 RSUs and a stock option for …

Edgewise Therapeutics (NASDAQ:EWTX) General Counsel Sells $219,801.12 in Stock

Edgewise Therapeutics General Counsel John Moore sold 5,016 shares of EWTX stock worth $219,801.12 to cover tax withholding obligations from vested equity awards, reducing his direct ownership by 22.08%. The company's stock is trading near its 52-week high, and despite missing recent earnings expectations, …

Edgewise Therapeutics (EWTX) grants CFO 24,375 RSUs and 48,750-share option

Edgewise Therapeutics (EWTX) has granted its CFO, Michael Nofi, 24,375 Restricted Stock Units (RSUs) and an option for 48,750 shares of common stock. The RSUs vest in four equal annual installments starting August 12, 2027, and the stock options vest monthly over 48 months …

RA Capital’s 7.8% Edgewise Therapeutics (EWTX) stake totals 8.39M shares

RA Capital Management, L.P. and its affiliated parties have reported a 7.8% stake in Edgewise Therapeutics, Inc. (EWTX), totaling 8,392,730 shares of common stock. This ownership is held by RA Capital Healthcare Fund, L.P., with RA Capital having shared voting and dispositive power over …

Edgewise Therapeutics (EWTX) grants 50,000 RSUs and 100,000 options to CBO

Edgewise Therapeutics reported that its Chief Business Officer, Derakhshan Behrad, received equity awards comprising 50,000 Restricted Stock Units (RSUs) and a stock option for 100,000 shares. Behrad also had 5,781 and 7,500 RSUs convert into common stock on August 12, 2026, and subsequently sold …

Ridgepost Capital Breaks Below 200-Day Moving Average - Notable for RPC

In trading on Friday, shares of Ridgepost Capital Inc Class A (Symbol: RPC) crossed below their 200 day moving average of $8.83, changing hands as low as $8.64 per share. Ridgepost Capital Inc Class A shares are currently trading off about 2.7% on the …

Badger Meter Raises Dividend 10% Representing 34 Years of Consecutive Annual Dividend Growth

MILWAUKEE, August 14, 2026--(BUSINESS WIRE)--The Board of Directors of Badger Meter, Inc. (NYSE: BMI) today authorized a 10% increase in its quarterly common stock dividend to $0.44 per share from $0.40 per share. The increased dividend is payable September 11, 2026, to shareholders of …

Bridgemarq Real Estate Services, Inc. (BRE) Q1 2025 Earnings Report - Results, Call & Slides

Chain Bridge I (OTC: CBGGF) reports loss, deficits and SPAC deadline risk

RLJ Lodging Trust (RLJ) preferred stakes reported by Virtus InfraCap and InfraCap funds

Chain Bridge I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Bridgeline Digital Ties Record New Customer Wins as AI Search Demand Accelerates

Bridgeline Digital reported strong fiscal third-quarter 2026 results, tying a company record with nine new customer wins and expanding relationships with ten existing accounts, driven by accelerating demand for its AI-powered HawkSearch platform. Core product revenue grew 13% on a trailing twelve-month basis, now …

Edgewise Therapeutics (EWTX): Baker Bros. discloses 3.4% ownership in Schedule 13G/A

StoneBridge Acquisition II Cuts Administrative Costs Via Waiver

StoneBridge Acquisition II Corp 2Q 2026: Net income $352348 EPS $0.04— 10-Q Summary

StoneBridge Acquisition II (APAC) outlines $59M trust, income and going concern risk

StoneBridge Acquisition II Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Seabridge Gold (NYSE: SA) posts $117.5M Q2 profit and advances KSM work

Seabridge Gold reported a significant increase in Q2 2026 net income to $117.5 million, largely due to gains from spinning out the Courageous Lake project. The company is actively advancing its KSM project with major field programs and infrastructure development, supported by a newly …

Suncor or Enbridge? Here’s the Better Dividend Stock This Year

This article compares Suncor Energy and Enbridge as dividend stock investments. While Enbridge offers a higher current yield and more stable operations, Suncor is highlighted for its strong balance sheet, potential upside from elevated energy prices, and aggressive share buybacks, making it the preferred …

Enbridge Inc. stock rises Friday, outperforms market

Enbridge Inc. (ENB) saw its stock rise by 0.16% to C$70.61 on Friday, outperforming the broader Canadian market where the S&P/TSX Composite Index fell by 0.08%. Despite this gain, the company's stock closed 12.4% below its 52-week high of C$80.65, achieved on May 22nd.

JPMorgan Chase & Co. Has Lowered Expectations for BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price

Seabridge Gold (NYSE:SA) Trading Up 6.1% - What's Next?

WaterBridge Infrastructure LLC (WBI) Stock Price, News, Quote & History

OXBRIDGE RE HOLDINGS Ltd Q2 2026: Revenue $368K, EPS $0.02— 10-Q Summary

OXBRIDGE RE HOLDINGS Ltd (OXBR) reported its second-quarter 2026 results, showing a return to profitability with $368K in revenue and $0.02 diluted EPS, compared to a net loss in the prior year. The company's financial performance was boosted by fee income from SurancePlus and …

Seabridge Gold (SA) Surges 3.87% to $33.41, Testing Key Resistance at $35.08 - Diamond Pattern

BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher.

One of the more high-flying stocks in the U.S. biotech sector these days is genetic-disease-focused BridgeBio Pharma (NASDAQ: BBIO). That's due almost entirely to the outperformance of its Attruby heart medication. If the generally bullish analyst sentiment on the company is anything to go …

Can AIG Turn Rising Cloud Risks Into Cyber Insurance Growth?

American International Group, I AIG is expanding its cyber insurance offering with a new Parametric Cloud Outage Solution for eligible business clients. Developed with technology monitoring specialist Parametrix, the solution protects businesses against financial losses from disruptions involving cloud infrastructure and software-as-a-service (SaaS) providers. …

BridgeBio Pharma's Transition to Rare Disease 'Commercial Powerhouse' On Track, RBC Says

BridgeBio Pharma's (BBIO) transition into a rare disease "commercial powerhouse" is on track and poised to accelerate, RBC Capital Markets said in a Friday note.The company's Attruby drug is gaining traction in first-line treatment settings, while the market for the drug Silver Upgrade to …

QuasarEdge Acquisition (QRED) investor files exit report after ownership falls to 0%

Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. have filed an amended Schedule 13G/A for QuasarEdge Acquisition Corp (QRED), reporting that their beneficial ownership of Class A shares has decreased to 0%. This change follows an internal reorganization effective June 30, 2026, and …